361 related articles for article (PubMed ID: 25455830)
1. Pilot the pulse: controlling the multiplicity of receptor dynamics.
Bock A; Kostenis E; Tränkle C; Lohse MJ; Mohr K
Trends Pharmacol Sci; 2014 Dec; 35(12):630-8. PubMed ID: 25455830
[TBL] [Abstract][Full Text] [Related]
2. Emerging structural insights into biased GPCR signaling.
Shukla AK; Singh G; Ghosh E
Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
[TBL] [Abstract][Full Text] [Related]
3. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
[TBL] [Abstract][Full Text] [Related]
4. When simple agonism is not enough: emerging modalities of GPCR ligands.
Smith NJ; Bennett KA; Milligan G
Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
[TBL] [Abstract][Full Text] [Related]
5. [G-protein-coupled receptors plasticity and signalling].
Galés C
Med Sci (Paris); 2012 Oct; 28(10):883-5. PubMed ID: 23067421
[TBL] [Abstract][Full Text] [Related]
6. The structure and dynamics of GPCR oligomers: a new focus in models of cell-signaling mechanisms and drug design.
Filizola M; Weinstein H
Curr Opin Drug Discov Devel; 2005 Sep; 8(5):577-84. PubMed ID: 16159019
[TBL] [Abstract][Full Text] [Related]
7. Modeling G protein-coupled receptors in complex with biased agonists.
Costanzi S
Trends Pharmacol Sci; 2014 Jun; 35(6):277-83. PubMed ID: 24793542
[TBL] [Abstract][Full Text] [Related]
8. Fulfilling the Promise of "Biased" G Protein-Coupled Receptor Agonism.
Luttrell LM; Maudsley S; Bohn LM
Mol Pharmacol; 2015 Sep; 88(3):579-88. PubMed ID: 26134495
[TBL] [Abstract][Full Text] [Related]
9. Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance.
Bosier B; Hermans E
Trends Pharmacol Sci; 2007 Aug; 28(8):438-46. PubMed ID: 17629964
[TBL] [Abstract][Full Text] [Related]
10. Molecular alliance-from orthosteric and allosteric ligands to dualsteric/bitopic agonists at G protein coupled receptors.
Mohr K; Schmitz J; Schrage R; Tränkle C; Holzgrabe U
Angew Chem Int Ed Engl; 2013 Jan; 52(2):508-16. PubMed ID: 23225228
[TBL] [Abstract][Full Text] [Related]
11. Towards tissue-specific pharmacology: insights from the calcium-sensing receptor as a paradigm for GPCR (patho)physiological bias.
Leach K; Conigrave AD; Sexton PM; Christopoulos A
Trends Pharmacol Sci; 2015 Apr; 36(4):215-25. PubMed ID: 25765207
[TBL] [Abstract][Full Text] [Related]
12. A kinetic view of GPCR allostery and biased agonism.
Lane JR; May LT; Parton RG; Sexton PM; Christopoulos A
Nat Chem Biol; 2017 Aug; 13(9):929-937. PubMed ID: 28820879
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
Kristiansen K
Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
[TBL] [Abstract][Full Text] [Related]
14. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor.
Hudson BD; Hébert TE; Kelly ME
Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905
[TBL] [Abstract][Full Text] [Related]
15. Refining efficacy: exploiting functional selectivity for drug discovery.
Gesty-Palmer D; Luttrell LM
Adv Pharmacol; 2011; 62():79-107. PubMed ID: 21907907
[TBL] [Abstract][Full Text] [Related]
16. Recent updates on GPCR biased agonism.
Pupo AS; Duarte DA; Lima V; Teixeira LB; Parreiras-E-Silva LT; Costa-Neto CM
Pharmacol Res; 2016 Oct; 112():49-57. PubMed ID: 26836887
[TBL] [Abstract][Full Text] [Related]
17. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
Valant C; Sexton PM; Christopoulos A
Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
[TBL] [Abstract][Full Text] [Related]
18. Biasing the parathyroid hormone receptor: relating in vitro ligand efficacy to in vivo biological activity.
Appleton KM; Lee MH; Alele C; Alele C; Luttrell DK; Peterson YK; Morinelli TA; Luttrell LM
Methods Enzymol; 2013; 522():229-62. PubMed ID: 23374189
[TBL] [Abstract][Full Text] [Related]
19. GPCR structures in drug design, emerging opportunities with new structures.
Tautermann CS
Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
[TBL] [Abstract][Full Text] [Related]
20. Conformational complexity of G-protein-coupled receptors.
Kobilka BK; Deupi X
Trends Pharmacol Sci; 2007 Aug; 28(8):397-406. PubMed ID: 17629961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
